Subhakrith Pharmaceutical Private Limited
About Subhakrith Pharmaceutical Private Limited
Data last updated:
Subhakrith Pharmaceutical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 January 2024.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21000TS2024PTC181262.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Maddileti Kuruva and Naresh Genedi.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹74,170. For the same year it recorded a net loss of ₹1.93 Lakh (net margin -259.9%) and EBITDA of -₹1.93 Lakh (EBITDA margin -259.9%).
Company details
Contact details
Subhakrith Pharmaceutical Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressH – No 3 – 10 – 99 Sy No 270, Rajiv Gandhi Nagar, Hyderabad, Telangana, India – 500090
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Subhakrith Pharmaceutical is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Subhakrith Pharmaceutical Private Limited, buy the company report.
Financials of Subhakrith Pharmaceutical Private Limited
FY 2025 filings availableSubhakrith Pharmaceutical Private Limited reported revenue of ₹74,170 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.93 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.93 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -259.9% | |
| Net Profit Margin | -259.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Subhakrith Pharmaceutical Private Limited, buy the company report.
Board of directors of Subhakrith Pharmaceutical Private Limited
Subhakrith Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maddileti Kuruva | Director | 20 Jan 2024 | 2 Years 9 Months | Current |
| Naresh Genedi | Director | 20 Jan 2024 | 2 Years 9 Months | Current |
Peer comparison
Subhakrith Pharmaceutical Private Limited is compared with the 6 companies closest to it by revenue in the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sodar Technologies Private Limited | ₹74,557 (FY 2025) | -8.0% | New Delhi, Delhi, India | |||
| Rhythmwaves Tech Solutions Private Limited | ₹74,389 (FY 2024) | 9.0% | Hyderabad, Telangana, India | |||
| Subhakrith Pharmaceutical Private Limitedthis company | ₹74,170 (FY 2025) | -₹1.93 Lakh | -259.9% | Hyderabad, Telangana, India | ||
| M - Square Metal Processors Private Limited | ₹74,016 (FY 2025) | -47.0% | Pune, Maharashtra, India | |||
| 3Bees Io Private Limited | ₹74,000 (FY 2022) | 562.0% | Bangalore, Karnataka, India | |||
| Iridia Solutions Private Limited | ₹74,000 (FY 2025) | 25.0% | Thalassery, Kerala, India | |||
| Vibranium Robotics Private Limited | ₹73,883 (FY 2025) | 287.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Subhakrith Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Subhakrith Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Subhakrith Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Subhakrith Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Subhakrith Pharmaceutical Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Maddileti Kuruva was appointed as Director on 20 Jan 2024.
Frequently asked questions
Subhakrith Pharmaceutical is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 January 2024 (2+ years old) and is registered under CIN U21000TS2024PTC181262.
Subhakrith Pharmaceutical has 2 current directors:
- Maddileti Kuruva - Director
- Naresh Genedi - Director
The latest financial statements of Subhakrith Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Subhakrith Pharmaceutical is U21000TS2024PTC181262. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Subhakrith Pharmaceutical was incorporated on 20 January 2024, making it 2+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Subhakrith Pharmaceutical by revenue are Sodar Technologies Private Limited, Rhythmwaves Tech Solutions Private Limited, M - Square Metal Processors Private Limited, 3Bees Io Private Limited, Iridia Solutions Private Limited and 1 more, all in the same principal business activity (other professional, scientific and technical activities).
Maddileti Kuruva was appointed as Director on 20 Jan 2024. Naresh Genedi was appointed as Director on 20 Jan 2024.
The registered office of Subhakrith Pharmaceutical is at H – No 3 – 10 – 99 Sy No 270, Rajiv Gandhi Nagar, Hyderabad, Telangana, India – 500090.
Subhakrith Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Subhakrith Pharmaceutical can be reached at its registered office: H – No 3 – 10 – 99 Sy No 270, Rajiv Gandhi Nagar, Hyderabad, Telangana, India – 500090.
Subhakrith Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
